{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:44:12Z","timestamp":1784205852333,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.clinthera.2021.09.005","type":"journal-article","created":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T18:10:05Z","timestamp":1635790205000},"page":"1843-1860","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Intra-Articular Injection of a Novel DVS Cross-Linked Hyaluronic Acid Manufactured by Biological Fermentation (YYD302) in Patients With Knee Osteoarthritis: A Double-Blind, Randomized, Multicenter, Noninferiority Study"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9156-1203","authenticated-orcid":false,"given":"Yong-Geun","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5123-6513","authenticated-orcid":false,"given":"Chul-Won","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Hyung","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo-Suk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Jun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"In","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Cheor","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oog-Jin","family":"Shon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Mo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6450-2339","authenticated-orcid":false,"given":"Jong-Keun","family":"Seon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Jun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong Bum","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Wan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Hwi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hoon","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2021.09.005_bib0001","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.joca.2010.09.014","article-title":"Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis\u2014meta-analysis","volume":"19","author":"Bannuru","year":"2011","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.clinthera.2021.09.005_bib0002","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1002\/art.24925","article-title":"Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis","volume":"61","author":"Bannuru","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2021.09.005_bib0003","doi-asserted-by":"crossref","first-page":"44","DOI":"10.5792\/ksrr.18.062","article-title":"Intra-articular recombinant human growth hormone injection compared with hyaluronic acid and placebo for an osteoarthritis model of New Zealand rabbits","volume":"31","author":"Lubis","year":"2019","journal-title":"Knee Surg Relat Res"},{"key":"10.1016\/j.clinthera.2021.09.005_bib0004","doi-asserted-by":"crossref","first-page":"129","DOI":"10.5792\/ksrr.16.061","article-title":"Hylan GF-20 viscosupplementation in the treatment of symptomatic osteoarthritis of the knee: clinical effect survivorship at 5 years","volume":"29","author":"Boutefnouchet","year":"2017","journal-title":"Knee Surg Relat Res"},{"key":"10.1016\/j.clinthera.2021.09.005_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226007","article-title":"A single intra-articular injection of 2.0% non-chemically modified sodium hyaluronate vs 0.8% Hylan G-F 20 in the treatment of symptomatic knee osteoarthritis: a 6-month, multicenter, randomized, controlled non-inferiority trial","volume":"14","author":"Maheu","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.clinthera.2021.09.005_bib0006","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.curtheres.2019.02.003","article-title":"Intra-articular hyaluronic acid in the symptomatic treatment of knee osteoarthritis: a meta-analysis of single-injection products","volume":"90","author":"Vincent","year":"2019","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.clinthera.2021.09.005_bib0007","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/ard.60.5.518","article-title":"Acute arthritis after intra-articular hyaluronate injection: onset of effusions without crystal","volume":"60","author":"Bernardeau","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2021.09.005_bib0008","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.2106\/00004623-200207000-00008","article-title":"Granulomatous inflammation after Hylan G-F 20 viscosupplementation of the knee: a report of six cases","volume":"84","author":"Chen","year":"2002","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.clinthera.2021.09.005_bib0009","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1053\/sarh.2002.50008","article-title":"Intra-articular hyaluronans: a review of product-specific safety profiles","volume":"32","author":"Hamburger","year":"2003","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2021.09.005_bib0010","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/1529-0131(200104)44:4<978::AID-ANR156>3.0.CO;2-N","article-title":"Bilateral symmetric inflammatory reaction to Hylan G-F 20 injection","volume":"44","author":"Martens","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2021.09.005_bib0011","first-page":"2611","article-title":"Are there distinctive inflammatory flares after Hylan G-F 20 intraarticular injections?","volume":"29","author":"Pullman-Mooar","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinthera.2021.09.005_bib0012","first-page":"1311","article-title":"Acute local reactions after intraarticular Hylan for osteoarthritis of the knee","volume":"22","author":"Puttick","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinthera.2021.09.005_bib0013","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1093\/rheumatology\/40.12.1425","article-title":"Systemic reaction to viscosupplementation for knee osteoarthritis","volume":"40","author":"Rees","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clinthera.2021.09.005_bib0014","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12891-017-1591-4","article-title":"Efficacy and safety of single injection of cross-linked sodium hyaluronate vs. three injections of high molecular weight sodium hyaluronate for osteoarthritis of the knee: a double-blind, randomized, multi-center, non-inferiority study","volume":"18","author":"Ha","year":"2017","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.clinthera.2021.09.005_bib0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2147\/OARRR.S162127","article-title":"Systematic clinical evidence review of NASHA (Durolane hyaluronic acid) for the treatment of knee osteoarthritis","volume":"10","author":"Leighton","year":"2018","journal-title":"Open Access Rheumatol"},{"key":"10.1016\/j.clinthera.2021.09.005_bib0016","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1177\/0363546515609599","article-title":"Product differences in intra-articular hyaluronic acids for osteoarthritis of the knee","volume":"44","author":"Altman","year":"2016","journal-title":"Am J Sports Med"},{"key":"10.1016\/j.clinthera.2021.09.005_bib0017","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/jisakos-2020-000438","article-title":"Differential characteristics and management of pseudoseptic arthritis following hyaluronic acid injection is a rare complication: a systematic review","volume":"6","author":"Sedrak","year":"2021","journal-title":"J ISAKOS"},{"key":"10.1016\/j.clinthera.2021.09.005_bib0018","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1007\/s00296-017-3803-5","article-title":"Safety and efficacy of bi-annual intra-articular LBSA0103 injections in patients with knee osteoarthritis","volume":"37","author":"Lee","year":"2017","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.clinthera.2021.09.005_bib0019","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.21596","article-title":"American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee","volume":"64","author":"Hochberg","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.clinthera.2021.09.005_bib0020","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/ard.16.4.494","article-title":"Radiological assessment of osteo-arthrosis","volume":"16","author":"Kellgren","year":"1957","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2021.09.005_bib0021","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2519\/jospt.1998.28.2.88","article-title":"Knee Injury and Osteoarthritis Outcome Score (KOOS)\u2014development of a self-administered outcome measure","volume":"28","author":"Roos","year":"1998","journal-title":"J Orthop Sports Phys Ther"},{"key":"10.1016\/j.clinthera.2021.09.005_bib0022","first-page":"1833","article-title":"Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee","volume":"15","author":"Bellamy","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinthera.2021.09.005_bib0023","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.joca.2004.02.001","article-title":"OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited","volume":"12","author":"Pham","year":"2004","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.clinthera.2021.09.005_bib0024","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.arth.2018.02.029","article-title":"How much pain is significant? Defining the minimal clinically important difference for the visual analog scale for pain after total joint arthroplasty","volume":"33","author":"Jonathan","year":"2018","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.clinthera.2021.09.005_bib0025","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.bja.2021.01.021","article-title":"Minimal clinically important differences in randomised clinical trials on pain management after total hip and knee arthroplasty: a systematic review","volume":"126","author":"Laigaard","year":"2021","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.clinthera.2021.09.005_bib0026","first-page":"11","article-title":"Synthesis and characterization of covalently crosslinked pH-responsive hyaluronic acid nanogels: effect of synthesis parameters","author":"Maiz-Fernandez","year":"2019","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.clinthera.2021.09.005_bib0027","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/871218","article-title":"Hyaluronic acid based hydrogels for regenerative medicine applications","volume":"2015","author":"Borzacchiello","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.clinthera.2021.09.005_bib0028","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.joca.2005.09.003","article-title":"A double-blind randomized controlled trial comparing alternate forms of high molecular weight hyaluronan for the treatment of osteoarthritis of the knee","volume":"14","author":"Kirchner","year":"2006","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.clinthera.2021.09.005_bib0029","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.2106\/00004623-200209000-00015","article-title":"Increased frequency of acute local reaction to intra-articular Hylan GF-20 (Synvisc) in patients receiving more than one course of treatment","volume":"84","author":"Leopold","year":"2002","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.clinthera.2021.09.005_bib0030","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1007\/s00167-018-5114-0","article-title":"Single intra-articular injection of lightly cross-linked hyaluronic acid reduces knee pain in symptomatic knee osteoarthritis: a multicenter, double-blind, randomized, placebo-controlled trial","volume":"27","author":"Petterson","year":"2019","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"10.1016\/j.clinthera.2021.09.005_bib0031","doi-asserted-by":"crossref","first-page":"106","DOI":"10.5152\/eurjrheum.2015.0019","article-title":"Short-term effect of the combination of hyaluronic acid, chondroitin sulfate, and keratin matrix on early symptomatic knee osteoarthritis","volume":"2","author":"Galluccio","year":"2015","journal-title":"Eur J Rheumatol"},{"key":"10.1016\/j.clinthera.2021.09.005_bib0032","first-page":"951","article-title":"A prospective, randomized, double-blind, placebo controlled study to evaluate the efficacy of intraarticular hyaluronic acid for osteoarthritis of the knee","volume":"33","author":"Petrella","year":"2006","journal-title":"J Rheumatol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929182100357X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929182100357X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:55:08Z","timestamp":1758963308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014929182100357X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S014929182100357X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2021.09.005","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intra-Articular Injection of a Novel DVS Cross-Linked Hyaluronic Acid Manufactured by Biological Fermentation (YYD302) in Patients With Knee Osteoarthritis: A Double-Blind, Randomized, Multicenter, Noninferiority Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2021.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}